A Clinical Trial to Evaluate the Recombinant SARS-CoV-2 Vaccine (CHO Cell) for COVID-19
Clinical trial NCT04869592 · COMPLETED
Trial details
- NCT number
- NCT04869592
- Sponsor
- National Vaccine and Serum Institute, China
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-25
- Primary completion
- 2023-08-29
- Enrollment
- 3100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.